Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 22, 2026.

Pathways that Regulate ROS Scavenging Enzymes, and Their Role in Defense Against Tissue Destruction in Periodontitis

Hiroyuki Kanzaki, Satoshi Wada, Tsuyoshi Narimiya and 6 more

Frontiers in Physiology · 2017 · Review

doi:10.3389/fphys.2017.00351

Abstract

Periodontitis, an inflammatory disease that affects the tissues surrounding the teeth, is a common disease worldwide. It is caused by a dysregulation of the host inflammatory response to bacterial infection, which leads to soft and hard tissue destruction. In particular, it is the excessive inflammation in response to bacterial plaque that leads to the release of reactive oxygen species (ROS) from neutrophils, which, then play a critical role in the destruction of periodontal tissue. Generally, ROS produced from immune cells exhibit an anti-bacterial effect and play a role in host defense and immune regulation. Excessive ROS, however, can exert cytotoxic effects, cause oxidative damage to proteins, and DNA, can interfere with cell growth and cell cycle progression, and induce apoptosis of gingival fibroblasts. Collectively, these effects enable ROS to directly induce periodontal tissue damage. Some ROS also act as intracellular signaling molecules during osteoclastogenesis, and can thus also play an indirect role in bone destruction. Cells have several protective mechanisms to manage such oxidative stress, most of which involve production of cytoprotective enzymes that scavenge ROS. These enzymes are transcriptionally regulated via NRF2, Sirtuin, and FOXO. Some reports indicate an association between periodontitis and these cytoprotective enzymes' regulatory axes, with superoxide dismutase (SOD) the most extensively investigated. In this review article, we discuss the role of oxidative stress in the tissue destruction manifest in periodontitis, and the mechanisms that protect against this oxidative stress.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Periodontitis is a common disease worldwide of the tissues surrounding the teeth, and is caused by bacterial infection. It is characterized by a dysregulation of the host inflammatory response, which eventually results in soft and hard tissue destruction (Mercado et al.,; Bartold et al., ). Tissue destruction in periodontitis is considered to result from an excessive inflammatory response to bacterial plaque. This leads to release of reactive oxygen species (ROS), such as hydrogen peroxide and superoxide, from neutrophils (Waddington et al.,; Canakci et al.,; Dahiya et al.,; Miricescu et al.,; Callaway and Jiang,; White et al., ), which results in oxidative stress—an imbalance between the production of ROS and antioxidant defenses.

Generally, ROS produced from immune cells exhibit an anti-bacterial effect and play a role in host defense and immune regulation (Baehner et al.,; Canakci et al., ). Excessive ROS however, can exert cytotoxic effects (Esterbauer et al., ), cause oxidative damage to proteins and DNA (Wells et al., ), can interfere with cell growth and cell cycle progression (Chang et al., ), and induce apoptosis (Yu et al., ) of gingival fibroblasts. This collectively enables ROS to directly induce periodontal tissue damage. Some ROS are also indirectly involved in periodontal tissue destruction through their role as intracellular signaling molecules in the osteoclastogenic pathway (Ha et al., ), and indeed, excessive activation of osteoclasts is a typical pathology in severe periodontitis.

Cells normally have several protective mechanisms against these oxidative stressors (Furukawa-Hibi et al.,; Kensler et al.,; Hsu et al., ), most of which involve the induction of cytoprotective enzymes that scavenge ROS (Mates and Sanchez-Jimenez, ). One protective mechanism involves nuclear factor E2-related factor 2 (NRF2), a master regulatory transcription factor for the synthesis of cytoprotective enzymes. NRF2 has been reported to be a negative regulator of osteoclastogenesis (Kanzaki et al.,,, ).

The relationship between periodontitis and ROS is illustrated in Figure 1. In this review article, we will discuss; (1) the role of oxidative stress in tissue destruction in periodontitis, and (2) mechanisms that protect against oxidative stress.

The role of oxidative stress in the tissue destruction in periodontitis

Increased ROS are a hallmark of inflammation induced by neutrophils against invading bacteria, and are involved in tissue destruction (Sheikhi et al.,,; Chapple et al.,; Matthews et al., ). Periodontal tissue destruction is caused, in part, by neutrophils exhibiting an excessive inflammatory response to bacterial plaque (Canakci et al.,; Miricescu et al., ), with a high volume of ROS also generated by neutrophils in periodontal tissues with chronic periodontitis (Matthews et al., ). ROS production in neutrophils is driven, in part, by nicotinamide adenine dinucleotide phosphate oxidase (NOX) and the purine degradation pathway, which is significantly accelerated in inflamed periodontal tissue (Giannopoulou et al.,; Barnes et al., ).

The release of ROS plays a critical role in periodontitis-associated tissue destruction, where ROS exert both direct and indirect effects on bone destruction. Directly, it can induce cytotoxic effects and oxidative damage to proteins and DNA. It can also interfere with cell growth and cell cycle progression (Chang et al., ), induce apoptosis (Yu et al., ) of gingival fibroblasts, and cause matrix degradation via the induction of matrix proteinases. Indirectly, ROS acts as an intracellular signaling molecule during osteoclastogenesis; an important process in hard tissue degeneration.

ROS exert cytotoxicity, such as peroxidation of lipids and phospholipids, against cells as well as the extracellular matrix (ECM). Additionally, protein aggregation through ROS-mediated oxidation (Squier and Bigelow,; Squier,; Friguet, ) leads to the breakdown of cell/tissue homeostasis (Hohn et al., ). ROS can also stimulate ECM degradation by inducing the breakdown of glycosaminoglycan (Fuchs and Schiller, ) and matrix proteinases (Dasgupta et al.,,; Kar et al., ).

In addition to having a direct cytotoxic effect, ROS can indirectly promote hard tissue degeneration through their role in osteoclastogenesis. Intracellular signaling molecules that mediate osteoclastogenesis, a signaling cascade central to the destruction of alveolar bone, include ROS (Bax et al.,; Ha et al., ). In hard tissue destruction, alveolar bone resorption is driven by osteoclasts, the tissue-specific macrophage polykaryon created by the differentiation of monocyte/macrophage precursors cells on the bone surface (Teitelbaum, ). Generation of osteoclasts requires physical contact between osteoclast precursor cells and specific mesenchymal cells, such as marrow stromal cells or osteoblasts (Udagawa et al., ). The key osteoclastogenic cytokine receptor activator of nuclear factor-kB ligand (RANKL) is a membrane-bound protein on osteoblasts and their precursors, which is recognized by the receptor, RANK, on marrow macrophages, thus prompting them to differentiate into osteoclasts (Lacey et al.,; Yasuda et al., ). In normal physiological circumstances, RANKL is principally expressed by mesenchymal cells of the osteoblast lineage, but in states of skeletal inflammation (Kong et al., ), as well as in periodontitis (Kawai et al., ), RANKL is produced in abundance by lymphocytes. Other key factors involved in osteoclastogenesis include TRAF6, RAC1, and NOX (Abo et al.,; Wong et al.,; Wang et al.,; Sasaki et al., ). The NOX homologs, NOX1, and NOX2, complementarily generate ROS during osteoclastogenesis (Sasaki et al., ).

Several reports have suggested that ROS signaling can lead to activation of mitogen-activated protein kinase (MAPK), phosphoinositide-3 kinase (PI3K), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) (Thannickal and Fanburg,; Droge, ). NF-kB, which mediates IκBα phosphorylation and degradation, was the first transcription factor shown to respond to ROS (Schreck et al., ). Pretreatment of osteoclasts with antioxidants, to inhibit oxidation, was shown to reduce RANKL-induced AKT, NF-kB, and extracellular signal-regulated kinase (ERK) activation (Ha et al., ). Coincidentally, NF-kB also plays a pivotal role in cytokine-induced periodontal tissue damage (Chapple, ). Application of an antioxidant inhibited the responses of osteoclast precursors to RANKL; including activation of c-Jun N-terminal kinase, p38 MAPK and ERK, and inhibited osteoclast differentiation (Lee et al., ). RANKL-mediated ROS induces long lasting Ca2+ oscillations that activate the transcription factor, nuclear factor of activated T-cells, cytoplasmic 1 (NFATC1) (Kim et al., ). Taken together, ROS cause hard tissue destruction via osteoclastogenesis, as well as soft tissue destruction.

Mechanisms that protect against oxidative stress

Cells normally possess several regulatory pathways that protect against oxidative stress (Furukawa-Hibi et al.,; Kensler et al.,; Hsu et al., ), by producing cytoprotective enzymes that scavenge ROS (Mates and Sanchez-Jimenez, ). NRF2 (Thimmulappa et al., ), Sirtuin (Chen et al., ), and FOXO (Liu et al., ) are major regulatory pathways for cytoprotective enzymes (Kanzaki et al., ). Figure 2 summarizes the linking the periodontitis, the regulatory pathways of ROS scavenging enzymes, and the defense mechanism against tissue destruction.

NRF2 transcriptionally induces cytoprotective enzymes, such as heme oxygenase-1 (HO-1) (Alam et al., ), NAD(P)H: quinone reductase (NQO1) (Favreau and Pickett, ), gamma-glutamylcysteine synthetase (GCS) (Wild et al., ), and the auxiliary cellular NADPH regenerating enzyme, glucose 6-phosphate dehydrogenase (G6PD) (Thimmulappa et al., ). In addition, Sirtuin- and FOXO-induced superoxide dismutase (SOD) (Kops et al.,; Nemoto and Finkel, ) convert superoxide to hydrogen peroxide (Baehner et al., ), which is subsequently detoxified by catalase (CAT) (Essers et al., ). These cytoprotective enzymes play a critical role in the scavenging and detoxification of ROS.

Maintaining a balance between ROS and antioxidants is essential for periodontal health. In patients with severe chronic periodontitis, down-regulation of the NRF2 pathway was observed in polymorphonuclear leucocytes (Sima et al., ). In addition, neutrophils from patients with severe chronic periodontitis exhibited hyper-reactivity to bacterial stimuli (Dias et al., ). Conversely, activation of NRF2 prevented alveolar bone loss in an experimental animal study (Bhattarai et al., ). In this context, downregulation of NRF2 pathway might lead to the increase in ROS, which causes tissue destruction.

Cytoprotective enzymes are also thought to interfere with osteoclastogenesis, where ROS functions as an intracellular signaling molecule (Ha et al., ). Indeed, RANKL stimulation decreases expression of NRF2-dependent cytoprotective enzymes, thereby facilitating intracellular ROS signaling (Kanzaki et al.,, ). Induction of cytoprotective enzymes by NRF2 activation subsequently inhibits osteoclastogenesis (Kanzaki et al.,,,; Sakai et al.,; Gambari et al.,; Lee et al.,; Lu et al.,; Bhattarai et al., ). Inversely, augmented osteoclastogenesis and bone destruction was observed with NRF2 deficiency (Rana et al.,; Hyeon et al.,; Ibanez et al.,; Lippross et al.,; Sun et al., ). Taken together, this shows that NRF2-dependent cytoprotective enzymes play a critical role in the regulation of bone destruction.

Enlargement of periapical lesions of the teeth in experimental animals has been associated with decreased expression of Sirtuin (SIRT6), causing increased apoptosis of osteoblasts (Kok et al., ). Activation of Sirtuin, by resveratrol (Tamaki et al., ) or overexpression of SIRT6 in osteoblasts by lentiviral gene transfer (Kok et al.,; Hou et al., ), inhibited bone destruction. Therefore, not only NRF2- but also Sirtuin-mediated cytoprotective mechanisms control periodontal tissue homeostasis.

Activated FOXOs enhance antioxidant defense by augmenting cytoprotective enzymes, which successfully prevent inflammation and bone destruction (Chung et al.,; Kousteni, ). FOXO activation directly inhibits osteoclastogenesis (Bartell et al.,; Tan et al., ). However, FOXO binds to β-catenin, which exhibits inhibitory effects on osteoblastic differentiation. Thus, continuous stimulation of the FOXO/β-catenin pathway may reduce bone formation (Galli et al., ). In addition, porphyromonas gingivalis-induced ROS activate FOXO transcription factors through JNK signaling, which resulted in the FOXO1-controlled oxidative stress responses, such as inflammatory cytokine production and cell survival (Wang et al., ).

A relationship between cytoprotective enzymes themselves and periodontitis has also been reported. SOD is one of the most extensively investigated enzymes, and is closely associated with periodontitis. A positive relationship was demonstrated between the progression of periodontitis and serum SOD concentrations in experimental animals (Sobaniec and Sobaniec-Lotowska, ). This has been confirmed in human gingival crevicular fluid (GCF) (Akalin et al.,; Wei et al., ), serum (Wei et al., ), and saliva SOD (Canakci et al.,; Guentsch et al.,; Karim et al., ). Clinical studies in humans indicate that periodontal therapy returns elevated SOD levels to normal (Novakovic et al.,,; Sukhtankar et al.,; Singh et al., ). Induction of SOD inhibited experimental periodontitis in animals (Petelin et al., ) and augmentation of anti-oxidant capacity by nutrient supplementation positively affected periodontal therapy in clinical trials (Biju et al.,; Daiya et al.,; Muniz et al., ). Furthermore, genetic mutation of SOD is considered to be a risk factor for periodontitis (Kazemi et al., ). These data support a role for SOD as a potential diagnostic marker for periodontitis. Therapeutically targeting SOD for the treatment of periodontitis may however produce substantive side effects, due to its beneficial effect on periodontopathogenic bacteria. SOD exhibited protective effects on the periodontopathogenic anaerobes Porphyromonas gingivalis (Lynch and Kuramitsu, ) and Aggregatibacter actinomycetemcomitans (Balashova et al., ).

HO-1 is another cytoprotective enzyme involved in the pathology of periodontitis. HO-1 inhibited RANKL upregulation in human cultured periodontal ligament cells (Lee et al., ) and lipopolysaccharide-induced production of proinflammatory mediators in cultured macrophages (Choi et al., ). Immunohistochemistry demonstrated that HO-1 was broadly expressed in periodontal tissue with chronic periodontitis (Gayathri et al., ). G6PD expression was also increased in the gingiva of patients with gingivitis (Di Paola et al.,; Yu et al., ). These data support the concept that the protective mechanisms provided by cytoprotective enzymes against ROS also play an inhibitory role in the progression of tissue destruction.

Clinically, it has been reported that markers of oxidative stress in saliva could serve as diagnostic markers for periodontitis (Sawamoto et al.,; Almerich-Silla et al.,; Banasova et al.,; Tothova et al., ) and therapeutic intervention against experimental periodontitis in rats improved total serum antioxidant levels (Saglam et al., ). A better understanding of the mechanisms that protect against oxidative stress will be useful for gaining a precise understanding of periodontitis pathology, which in turn, will contribute to the development of therapies for periodontitis treatment.

Summary and perspective

In this review, we have summarized recent evidence of the relationship between oxidative stress and periodontitis, a disease in which oxidative stress is both directly and indirectly involved with tissue destruction. Many reports describe a relationship between oxidative stress and periodontitis, with the balance between oxidative stress and defense mechanisms characterizing the pathological condition of the periodontitis. As such, some enzymes that are cytoprotective against oxidative stress could serve as diagnostic markers for periodontitis. Furthermore, a strong potential therapeutic approach for periodontitis would be to augment enzymes that protect against oxidative stress.

Although oxidative stress in periodontitis has been extensively investigated, there remains little information about the relationship between tissue damage and the immunological reactions exerted via ROS production in immune cells. Further investigation in this area is urgently needed for a comprehensive understanding of periodontitis.

Author contributions

Conception and design: HK and YN. Search references: SW, TN, YY, YN, YK, KI, SF, and YM. Drafted manuscript: HK, SW, YY, and YN. Critically revised the manuscript: HK, SW, YY, YK, KI, SF, YM, and YN.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 113

  1. 1.

    Abo A. Pick E. Hall A. Totty N. Teahan C. G. Segal A. W. (1991 ). Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353, 668–670.

    Not in our library10.1038/353668a0

  2. 2.

    Akalin F. A. Toklu E. Renda N. (2005 ). Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J. Clin. Periodontol. 32, 238–243.

    Not in our library10.1111/j.1600-051x.2005.00669.x

  3. 3.

    Alam J. Stewart D. Touchard C. Boinapally S. Choi A. M. Cook J. L. (1999 ). Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274, 26071–26078.

    Not in our library10.1074/jbc.274.37.26071

  4. 4.

    Almerich-Silla J. M. Montiel-Company J. M. Pastor S. Serrano F. Puig-Silla M. Dasi F. (2015 ). Oxidative stress parameters in saliva and its association with periodontal disease and types of bacteria. Dis. Markers 2015:653537.

    Not in our library10.1155/2015/653537

  5. 5.

    Baehner R. L. Murrmann S. K. Davis J. Johnston R. B. Jr. (1975 ). The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J. Clin. Invest. 56, 571–576.

    Not in our library10.1172/jci108126

  6. 6.

    Balashova N. V. Park D. H. Patel J. K. Figurski D. H. Kachlany S. C. (2007 ). Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans. Infect. Immun. 75, 4490–4497.

    Not in our library10.1128/iai.00288-07

  7. 7.

    Banasova L. Kamodyova N. Jansakova K. Tothova L. Stanko P. Turna J.. (2015 ). Salivary DNA and markers of oxidative stress in patients with chronic periodontitis. Clin. Oral Investig. 19, 201–207.

    Not in our library10.1007/s00784-014-1236-z

  8. 8.

    Barnes V. M. Teles R. Trivedi H. M. Devizio W. Xu T. Mitchell M. W.. (2009 ). Acceleration of purine degradation by periodontal diseases. J. Dent. Res. 88, 851–855.

    Not in our library10.1177/0022034509341967

  9. 9.
    FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation · 2014
    No notice
  10. 10.

    Bartold P. M. Marshall R. I. Haynes D. R. (2005 ). Periodontitis and rheumatoid arthritis: a review. J. Periodontol. 76, 2066–2074.

    Not in our library10.1902/jop.2005.76.11-s.2066

  11. 11.

    Bax B. E. Alam A. S. Banerji B. Bax C. M. Bevis P. J. Stevens C. R.. (1992 ). Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem. Biophys. Res. Commun. 183, 1153–1158.

    Not in our library10.1016/s0006-291x(05)80311-0

  12. 12.

    Bhattarai G. Poudel S. B. Kook S. H. Lee J. C. (2016 ). Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 29, 398–408.

    Not in our library10.1016/j.actbio.2015.10.031

  13. 13.

    Biju T. Shabeer M. M. Amitha R. Rajendra B. P. Suchetha K. (2014 ). Comparative evaluation of serum superoxide dismutase and glutathione levels in periodontally diseased patients: an interventional study. Indian J. Dent. Res. 25, 613–616.

    Not in our library10.4103/0970-9290.147105

  14. 14.

    Callaway D. A. Jiang J. X. (2015 ). Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases. J. Bone Miner. Metab. 33, 359–370.

    Not in our library10.1007/s00774-015-0656-4

  15. 15.

    Canakci C. F. Cicek Y. Canakci V. (2005 ). Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry (Mosc). 70, 619–628.

    Not in our library10.1007/s10541-005-0161-9

  16. 16.

    Canakci C. F. Cicek Y. Yildirim A. Sezer U. Canakci V. (2009 ). Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur. J. Dent. 3, 100–106.

    Not in our library

  17. 17.

    Chang M. C. Tsai Y. L. Chen Y. W. Chan C. P. Huang C. F. Lan W. C.. (2013 ). Butyrate induces reactive oxygen species production and affects cell cycle progression in human gingival fibroblasts. J. Periodont. Res. 48, 66–73.

    Not in our library10.1111/j.1600-0765.2012.01504.x

  18. 18.

    Chapple L. (1997 ). Reactive oxygen species and antioxidants in inflammatory diseases. J. Clin. Periodontol. 24, 287–296.

    Not in our library10.1111/j.1600-051x.1997.tb00760.x

  19. 19.

    Chapple L. Brock G. R. Milward M. R. Ling N. Matthews J. B. (2007 ). Compromised GCF total antioxidant capacity in periodontitis: cause or effect? J. Clin. Periodontol. 34, 103–110.

    Not in our library10.1111/j.1600-051x.2006.01029.x

  20. 20.

    Chen Y. Zhang J. Lin Y. Lei Q. Guan K. L. Zhao S.. (2011 ). Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 12, 534–541.

    Not in our library10.1038/embor.2011.65

  21. 21.

    Choi E. Y. Jin J. Y. Choi J. I. Choi I. S. Kim S. J. (2014 ). DHA suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages. Br. J. Nutr. 111, 1221–1230.

    Not in our library10.1017/s0007114513003681

  22. 22.

    Chung H. Y. Lee E. K. Choi Y. J. Kim J. M. Kim D. H. Zou Y.. (2011 ). Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J. Dent. Res. 90, 830–840.

    Not in our library10.1177/0022034510387794

  23. 23.
    Reactive oxygen species in periodontitis · 2013
    Not checked
  24. 24.

    Daiya S. Sharma R. K. Tewari S. Narula S. C. Kumar Sehgal P. (2014 ). Micronutrients and superoxide dismutase in postmenopausal women with chronic periodontitis: a pilot interventional study. J. Periodontal Implant Sci. 44, 207–213.

    Not in our library10.5051/jpis.2014.44.4.207

  25. 25.

    Dasgupta J. Kar S. Liu R. Joseph J. Kalyanaraman B. Remington S. J.. (2010 ). Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J. Cell. Physiol. 225, 52–62.

    Not in our library10.1002/jcp.22193

  26. 26.

    Dasgupta J. Kar S. Van Remmen H. Melendez J. A. (2009 ). Age-dependent increases in interstitial collagenase and MAP Kinase levels are exacerbated by superoxide dismutase deficiencies. Exp. Gerontol. 44, 503–510.

    Not in our library10.1016/j.exger.2009.04.005

  27. 27.

    Dias H. Chapple I. L. Milward M. Grant M. M. Hill E. Brown J.. (2013 ). Sulforaphane restores cellular glutathione levels and reduces chronic periodontitis neutrophil hyperactivity in vitro. PLoS ONE 8:e66407.

    Not in our library10.1371/journal.pone.0066407

  28. 28.

    Di Paola R. Mazzon E. Rotondo F. Dattola F. Britti D. De Majo M.. (2005 ). Reduced development of experimental periodontitis by treatment with M40403, a superoxide dismutase mimetic. Eur. J. Pharmacol. 516, 151–157.

    Not in our library10.1016/j.ejphar.2005.04.039

  29. 29.

    Droge W. (2002 ). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47–95.

    Not in our library10.1152/physrev.00018.2001

  30. 30.

    Essers M. A. Weijzen S. de Vries-Smits A. M. Saarloos I. de Ruiter N. D. Bos J. L.. (2004 ). FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23, 4802–4812.

    Not in our library10.1038/sj.emboj.7600476

  31. 31.

    Esterbauer H. Schaur R. J. Zollner H. (1991 ). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81–128.

    Not in our library10.1016/0891-5849(91)90192-6

  32. 32.

    Favreau L. V. Pickett C. B. (1991 ). Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 266, 4556–4561.

    Not in our library

  33. 33.

    Friguet B. (2002 ). Protein repair and degradation during aging. Sci. World J. 2, 248–254.

    Not in our library10.1100/tsw.2002.98

  34. 34.

    Fuchs B. Schiller J. (2014 ). Glycosaminoglycan degradation by selected reactive oxygen species. Antioxid. Redox Signal. 21, 1044–1062.

    Not in our library10.1089/ars.2013.5634

  35. 35.

    Furukawa-Hibi Y. Kobayashi Y. Chen C. Motoyama N. (2005 ). FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid. Redox Signal. 7, 752–760.

    Not in our library10.1089/ars.2005.7.752

  36. 36.

    Galli C. Passeri G. Macaluso G. M. (2011 ). FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena? J. Periodont. Res. 46, 397–406.

    Not in our library10.1111/j.1600-0765.2011.01354.x

  37. 37.

    Gambari L. Lisignoli G. Cattini L. Manferdini C. Facchini A. Grassi F. (2014 ). Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism. Pharmacol. Res. 87, 99–112.

    Not in our library10.1016/j.phrs.2014.06.014

  38. 38.

    Gayathri G. Muthukumar S. Joseph L. D. Suresh R. (2014 ). Immunolocalization of heme oxygenase-1 in periodontal diseases. Indian J. Dent. Res. 25, 567–571.

    Not in our library10.4103/0970-9290.147080

  39. 39.

    Giannopoulou C. Krause K. H. Muller F. (2008 ). The NADPH oxidase NOX2 plays a role in periodontal pathologies. Semin. Immunopathol. 30, 273–278.

    Not in our library10.1007/s00281-008-0128-1

  40. 40.

    Guentsch A. Hiese I. Puklo M. Kiehntopf M. Pfister W. Eick S. (2012 ). Variables of host response in saliva of patients with periodontitis: a pilot study. Quintessence Int. 43, e104–e114.

    Not in our library

  41. 41.

    Ha H. Kwak H. B. Lee S. W. Jin H. M. Kim H. M. Kim H. H.. (2004 ). Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. Cell Res. 301, 119–127.

    Not in our library10.1016/j.yexcr.2004.07.035

  42. 42.

    Hohn T. Jung T. Grune T. (2014 ). Pathophysiological importance of aggregated damaged proteins. Free Radic. Biol. Med. 71, 70–89.

    Not in our library10.1016/j.freeradbiomed.2014.02.028

  43. 43.

    Hou K. L. Lin S. K. Chao L. H. Hsiang-Hua Lai E. Chang C. C. Shun C. T.. (2016 ). Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis-A therapeutic implication in inflammatory bone resorption. Biofactors 43, 170–180.

    Not in our library10.1002/biof.1320

  44. 44.

    Hsu C. P. Odewale I. Alcendor R. R. Sadoshima J. (2008 ). Sirt1 protects the heart from aging and stress. Biol. Chem. 389, 221–231.

    Not in our library10.1515/bc.2008.032

  45. 45.

    Hyeon S. Lee H. Yang Y. Jeong W. (2013 ). Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radic. Biol. Med. 65, 789–799.

    Not in our library10.1016/j.freeradbiomed.2013.08.005

  46. 46.

    Ibanez L. Ferrandiz M. L. Brines R. Guede D. Cuadrado A. Alcaraz M. J. (2014 ). Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis. Oxid. Med. Cell. Longev. 2014:726590.

    Not in our library10.1155/2014/726590

  47. 47.

    Kanzaki H. Shinohara F. Itohiya-Kasuya K. Ishikawa M. Nakamura Y. (2015 ). Nrf2 activation attenuates both orthodontic tooth movement and relapse. J. Dent. Res. 94, 787–794.

    Not in our library10.1177/0022034515577814

  48. 48.

    Kanzaki H. Shinohara F. Itohiya K. Yamaguchi Y. Katsumata Y. Matsuzawa M.. (2016b ). RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice. FASEB J. 31, 781–792.

    Not in our library10.1096/fj.201600826r

  49. 49.

    Kanzaki H. Shinohara F. Kajiya M. Fukaya S. Miyamoto Y. Nakamura Y. (2014 ). Nuclear nrf2 induction by protein transduction attenuates osteoclastogenesis. Free Radic. Biol. Med. 77, 239–248.

    Not in our library10.1016/j.freeradbiomed.2014.09.006

  50. 50.
    The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species Signaling · 2013
    Corrected
  51. 51.

    Kanzaki H. Shinohara F. Kanako I. Yamaguchi Y. Fukaya S. Miyamoto Y.. (2016a ). Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes. Redox Biol. 8, 186–191.

    Not in our library10.1016/j.redox.2016.01.006

  52. 52.

    Kar S. Subbaram S. Carrico P. M. Melendez J. A. (2010 ). Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir. Physiol. Neurobiol. 174, 299–306.

    Not in our library10.1016/j.resp.2010.08.019

  53. 53.

    Karim S. Pratibha P. K. Kamath S. Bhat G. S. Kamath U. Dutta B.. (2012 ). Superoxide dismutase enzyme and thiol antioxidants in gingival crevicular fluid and saliva. Dent. Res. J. (Isfahan). 9, 266–272.

    Not in our library

  54. 54.

    Kawai T. Matsuyama T. Hosokawa Y. Makihira S. Seki M. Karimbux N. Y.. (2006 ). B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169, 987–998.

    Not in our library10.2353/ajpath.2006.060180

  55. 55.

    Kazemi E. Moradi M. T. Yari K. Mousavi S. A. Kahrizi D. (2015 ). Association between Manganese Superoxide Dismutase (MnSOD Val-9Ala) genotypes with the risk of generalized aggressive periodontitis disease. Cell. Mol. Biol. (Noisy-le-grand). 61, 49–52.

    Not in our library

  56. 56.

    Kensler T. W. Wakabayashi N. Biswal S. (2007 ). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89–116.

    Not in our library10.1146/annurev.pharmtox.46.120604.141046

  57. 57.

    Kim M. S. Yang Y. M. Son A. Tian Y. S. Lee S. I. Kang S. W.. (2010 ). RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. J. Biol. Chem. 285, 6913–6921.

    Not in our library10.1074/jbc.m109.051557

  58. 58.

    Kok S. H. Hou K. L. Hong C. Y. Chao L. H. Hsiang-Hua Lai E. Wang H. W.. (2015 ). Sirtuin 6 modulates hypoxia-induced apoptosis in osteoblasts via inhibition of glycolysis: implication for pathogenesis of periapical lesions. J. Endod. 41, 1631–1637.

    Not in our library10.1016/j.joen.2015.05.008

  59. 59.

    Kong Y. Y. Feige U. Sarosi I. Bolon B. Tafuri A. Morony S.. (1999 ). Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304–309.

    Not in our library10.1038/46303

  60. 60.

    Kops G. J. Dansen T. B. Polderman P. E. Saarloos I. Wirtz K. W. Coffer P. J.. (2002 ). Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316–321.

    Not in our library10.1038/nature01036

  61. 61.

    Kousteni S. (2011 ). FoxOs: unifying links between oxidative stress and skeletal homeostasis. Curr. Osteoporos. Rep. 9, 60–66.

    Not in our library10.1007/s11914-011-0054-3

  62. 62.

    Lacey D. L. Timms E. Tan H. L. Kelley M. J. Dunstan C. R. Burgess T.. (1998 ). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176.

    Not in our library10.1016/s0092-8674(00)81569-x

  63. 63.

    Lee H. J. Jeong G. S. Pi S. H. Lee S. I. Bae W. J. Kim S. J.. (2010 ). Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression. J. Periodont. Res. 45, 367–374.

    Not in our library10.1111/j.1600-0765.2009.01247.x

  64. 64.

    Lee N. K. Choi Y. G. Baik J. Y. Han S. Y. Jeong D. W. Bae Y. S.. (2005 ). A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852–859.

    Not in our library10.1182/blood-2004-09-3662

  65. 65.

    Lee S. H. Kim J. K. Jang H. D. (2014 ). Genistein inhibits osteoclastic differentiation of RAW 264.7 cells via regulation of ROS production and scavenging. Int. J. Mol. Sci. 15, 10605–10621.

    Not in our library10.3390/ijms150610605

  66. 66.

    Lippross S. Beckmann R. Streubesand N. Ayub F. Tohidnezhad M. Campbell G.. (2014 ). Nrf2 deficiency impairs fracture healing in mice. Calcif. Tissue Int. 95, 349–361.

    Not in our library10.1007/s00223-014-9900-5

  67. 67.

    Liu J. W. Chandra D. Rudd M. D. Butler A. P. Pallotta V. Brown D.. (2005 ). Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene 24, 2020–2031.

    Not in our library10.1038/sj.onc.1208385

  68. 68.

    Lu S. H. Chen T. H. Chou T. C. (2015 ). Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression. J. Nat. Prod. 78, 61–68.

    Not in our library10.1021/np500663y

  69. 69.

    Lynch M. C. Kuramitsu H. K. (1999 ). Role of superoxide dismutase activity in the physiology of Porphyromonas gingivalis. Infect. Immun. 67, 3367–3375.

    Not in our library10.1128/iai.67.7.3367-3375.1999

  70. 70.

    Mates J. M. Sanchez-Jimenez F. (1999 ). Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 4:D339–D345.

    Not in our library10.2741/a432

  71. 71.

    Matthews J. B. Wright H. J. Roberts A. Cooper P. R. Chapple I. L. (2007b ). Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin. Exp. Immunol. 147, 255–264.

    Not in our library10.1111/j.1365-2249.2006.03276.x

  72. 72.

    Matthews J. B. Wright H. J. Roberts A. Ling-Mountford N. Cooper P. R. Chapple I. L. (2007a ). Neutrophil hyper-responsiveness in periodontitis. J. Dent. Res. 86, 718–722.

    Not in our library10.1177/154405910708600806

  73. 73.

    Mercado F. B. Marshall R. I. Bartold P. M. (2003 ). Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J. Clin. Periodontol. 30, 761–772.

    Not in our library10.1034/j.1600-051x.2003.00371.x

  74. 74.

    Miricescu D. Totan A. Calenic B. Mocanu B. Didilescu A. Mohora M.. (2014 ). Salivary biomarkers: relationship between oxidative stress and alveolar bone loss in chronic periodontitis. Acta Odontol. Scand. 72, 42–47.

    Not in our library10.3109/00016357.2013.795659

  75. 75.

    Muniz F. W. Nogueira S. B. Mendes F. L. Rosing C. K. Moreira M. M. de Andrade G. M.. (2015 ). The impact of antioxidant agents complimentary to periodontal therapy on oxidative stress and periodontal outcomes: a systematic review. Arch. Oral Biol. 60, 1203–1214.

    Not in our library10.1016/j.archoralbio.2015.05.007

  76. 76.

    Nemoto S. Finkel T. (2002 ). Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450–2452.

    Not in our library10.1126/science.1069004

  77. 77.

    Novakovic N. Cakic S. Todorovic T. Raicevic B. A. Dozic I. Petrovic V.. (2013 ). Antioxidative status of saliva before and after non-surgical periodontal treatment. Srp. Arh. Celok. Lek. 141, 163–168.

    Not in our library10.2298/sarh1304163n

  78. 78.

    Novakovic N. Todorovic T. Rakic M. Milinkovic I. Dozic I. Jankovic S.. (2014 ). Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome. J. Periodont. Res. 49, 129–136.

    Not in our library10.1111/jre.12088

  79. 79.

    Petelin M. Pavlica Z. Ivanusa T. Sentjurc M. Skaleric U. (2000 ). Local delivery of liposome-encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles. J. Clin. Periodontol. 27, 918–925.

    Not in our library10.1034/j.1600-051x.2000.027012918.x

  80. 80.

    Rana T. Schultz M. A. Freeman M. L. Biswas S. (2012 ). Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL. Free Radic. Biol. Med. 53, 2298–2307.

    Not in our library10.1016/j.freeradbiomed.2012.10.536

  81. 81.

    Saglam M. Koseoglu S. Hatipoglu M. Esen H. H. Koksal E. (2015 ). Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. J. Appl. Oral Sci. 23, 33–41.

    Not in our library10.1590/1678-775720140288

  82. 82.

    Sakai E. Shimada-Sugawara M. Yamaguchi Y. Sakamoto H. Fumimoto R. Fukuma Y.. (2013 ). Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. J. Pharmacol. Sci. 121, 288–298.

    Not in our library10.1254/jphs.12243fp

  83. 83.

    Sasaki H. Yamamoto H. Tominaga K. Masuda K. Kawai T. Teshima-Kondo S.. (2009a ). NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J. Med. Invest. 56, 33–41.

    Not in our library10.2152/jmi.56.33

  84. 84.

    Sasaki H. Yamamoto H. Tominaga K. Masuda K. Kawai T. Teshima-Kondo S.. (2009b ). Receptor activator of nuclear factor- κB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Free Radic. Biol. Med. 47, 189–199.

    Not in our library10.1016/j.freeradbiomed.2009.04.025

  85. 85.

    Sawamoto Y. Sugano N. Tanaka H. Ito K. (2005 ). Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiol. Immunol. 20, 216–220.

    Not in our library10.1111/j.1399-302x.2005.00215.x

  86. 86.

    Schreck R. Rieber P. Baeuerle P. A. (1991 ). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 2247–2258.

    Not in our library10.1002/j.1460-2075.1991.tb07761.x

  87. 87.

    Sheikhi M. Bouhafs R. K. Hammarstrom K. J. Jarstrand C. (2001 ). Lipid peroxidation caused by oxygen radicals from Fusobacterium-stimulated neutrophils as a possible model for the emergence of periodontitis. Oral Dis. 7, 41–46.

    Not in our library

  88. 88.

    Sheikhi M. Gustafsson A. Jarstrand C. (2000 ). Cytokine, elastase and oxygen radical release by Fusobacterium nucleatum-activated leukocytes: a possible pathogenic factor in periodontitis. J. Clin. Periodontol. 27, 758–762.

    Not in our library10.1034/j.1600-051x.2000.027010758.x

  89. 89.

    Sima C. Aboodi G. M. Lakschevitz F. S. Sun C. Goldberg M. B. Glogauer M. (2016 ). Nuclear factor erythroid 2-related factor 2 down-regulation in oral neutrophils is associated with periodontal oxidative damage and severe chronic periodontitis. Am. J. Pathol. 186, 1417–1426.

    Not in our library10.1016/j.ajpath.2016.01.013

  90. 90.

    Singh N. Chander Narula S. Kumar Sharma R. Tewari S. Kumar Sehgal P. (2014 ). Vitamin E supplementation, superoxide dismutase status, and outcome of scaling and root planing in patients with chronic periodontitis: a randomized clinical trial. J Periodontol. 85, 242–249.

    Not in our library10.1902/jop.2013.120727

  91. 91.

    Sobaniec H. Sobaniec-Lotowska M. E. (2000 ). Morphological examinations of hard tissues of periodontium and evaluation of selected processes of lipid peroxidation in blood serum of rats in the course of experimental periodontitis. Med. Sci. Monit. 6, 875–881.

    Not in our library

  92. 92.

    Squier T. C. (2001 ). Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 36, 1539–1550.

    Not in our library10.1016/s0531-5565(01)00139-5

  93. 93.

    Squier T. C. Bigelow D. J. (2000 ). Protein oxidation and age-dependent alterations in calcium homeostasis. Front. Biosci. 5:D504–D526.

    Not in our library10.2741/a530

  94. 94.

    Sukhtankar L. Kulloli A. Kathariya R. Shetty S. (2013 ). Effect of non-surgical periodontal therapy on superoxide dismutase levels in gingival tissues of chronic periodontitis patients: a clinical and spectophotometric analysis. Dis. Markers 34, 305–311.

    Not in our library10.1155/2013/269027

  95. 95.

    Sun Y. X. Li L. Corry K. A. Zhang P. Yang Y. Himes E.. (2015 ). Deletion of Nrf2 reduces skeletal mechanical properties and decreases load-driven bone formation. Bone 74, 1–9.

    Not in our library10.1016/j.bone.2014.12.066

  96. 96.

    Tamaki N. Cristina Orihuela-Campos R. Inagaki Y. Fukui M. Nagata T. Ito H. O. (2014 ). Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model. Free Radic. Biol. Med. 75, 222–229.

    Not in our library10.1016/j.freeradbiomed.2014.07.034

  97. 97.

    Tan P. Guan H. Xie L. Mi B. Fang Z. Li J.. (2015 ). FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC. Sci. Rep. 5:16835.

    Not in our library10.1038/srep16835

  98. 98.

    Teitelbaum S. L. (2000 ). Bone resorption by osteoclasts. Science 289, 1504–1508.

    Not in our library10.1126/science.289.5484.1504

  99. 99.

    Thannickal V. J. Fanburg B. L. (2000 ). Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol., 279, L1005–L1028.

    Not in our library10.1152/ajplung.2000.279.6.l1005

  100. 100.

    Thimmulappa R. K. Mai K. H. Srisuma S. Kensler T. W. Yamamoto M. Biswal S. (2002 ). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62, 5196–5203.

    Not in our library

  101. 101.
    Salivary markers of oxidative stress in oral diseases · 2015
    No notice
  102. 102.

    Udagawa N. Takahashi N. Akatsu T. Tanaka H. Sasaki T. Nishihara T.. (1990 ). Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. U.S.A. 87, 7260–7264.

    Not in our library10.1073/pnas.87.18.7260

  103. 103.

    Waddington R. J. Moseley R. Embery G. (2000 ). Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis. 6, 138–151.

    Not in our library10.1111/j.1601-0825.2000.tb00325.x

  104. 104.

    Wang Q. Sztukowska M. Ojo A. Scott D. A. Wang H. Lamont R. J. (2015 ). FOXO responses to Porphyromonas gingivalis in epithelial cells. Cell. Microbiol. 17, 1605–1617.

    Not in our library10.1111/cmi.12459

  105. 105.

    Wang Y. Lebowitz D. Sun C. Thang H. Grynpas M. D. Glogauer M. (2008 ). Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. J. Bone Miner. Res. 23, 260–270.

    Not in our library10.1359/jbmr.071013

  106. 106.

    Wei D. Zhang X. L. Wang Y. Z. Yang C. X. Chen G. (2010 ). Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust. Dent. J. 55, 70–78.

    Not in our library10.1111/j.1834-7819.2009.01123.x

  107. 107.

    Wells P. G. McCallum G. P. Chen C. S. Henderson J. T. Lee C. J. J. Perstin J.. (2009 ). Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol. Sci. 108, 4–18.

    Not in our library10.1093/toxsci/kfn263

  108. 108.

    White P. C. Chicca I. J. Cooper P. R. Milward M. R. Chapple I. L. (2016 ). Neutrophil extracellular traps in periodontitis: a web of intrigue. J. Dent. Res. 95, 26–34.

    Not in our library10.1177/0022034515609097

  109. 109.

    Wild C. Gipp J. J. Mulcahy T. (1998 ). Overlapping antioxidant response element and PMA response element sequences mediate basal and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase catalytic subunit gene. Biochem. J. 332(Pt 2), 373–381.

    Not in our library10.1042/bj3320373

  110. 110.

    Wong B. R. Josien R. Lee S. Y. Vologodskaia M. Steinman R. M. Choi Y. (1998 ). The TRAF family of signal transducers mediates NF- κB activation by the TRANCE receptor. J. Biol. Chem. 273, 28355–28359.

    Not in our library10.1074/jbc.273.43.28355

  111. 111.

    Yasuda H. Shima N. Nakagawa N. Yamaguchi K. Kinosaki M. Mochizuki S.. (1998 ). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95, 3597–3602.

    Not in our library10.1073/pnas.95.7.3597

  112. 112.

    Yu J. Y. Lee S. Y. Son Y. O. Shi X. Park S. S. Lee J. C. (2012 ). Continuous presence of H(2)O(2) induces mitochondrial-mediated, MAPK- and caspase-independent growth inhibition and cytotoxicity in human gingival fibroblasts. Toxicol. In vitro 26, 561–570.

    Not in our library10.1016/j.tiv.2012.01.022

  113. 113.

    Yu N. Barros S. P. Zhang S. Moss K. L. Phillips S. T. Offenbacher S. (2015 ). Insulin response genes in different stages of periodontal disease. J. Dent. Res. 94(Suppl. 9), 194S–200S.

    Not in our library10.1177/0022034515584384

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.